Effects of chitosan oligosaccharides on drug-metabolizing enzymes in rat liver and kidneys

Food and Chemical Toxicology

Volumn 50, Issue 5, 2012, Pages 1171-1177

  Yao, Hsien Tsung ^a   Luo, Mei Ning ^a   Hung, Lang Bang ^b   Chiang, Meng Tsan ^b   Lin, Jia Hsuan ^a   Lii, Chong Kuei ^a   Huang, Chun Yin ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN OCEAN UNIVERSITY   (Taiwan)

Author keywords

Chitosan oligosaccharides; Drug metabolizing enzymes; Kidneys; Liver; Oxidative stress; Rats

Indexed keywords

CHITOSAN OLIGOSACCHARIDE; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 2B; CYTOCHROME P450 2C; CYTOCHROME P450 2D; CYTOCHROME P450 2E1; CYTOCHROME P450 3A; CYTOCHROME P450 4A; DRUG METABOLIZING ENZYME; GLUCURONOSYLTRANSFERASE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; OLIGOSACCHARIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CATALYSIS; CONTROLLED STUDY; DIETARY INTAKE; ENZYME ACTIVITY; HYDROXYLATION; IMMUNOBLOTTING; KIDNEY; KIDNEY MICROSOME; LIVER; LIVER MICROSOME; MALE; NONHUMAN; RAT;

ANIMALS; BLOTTING, WESTERN; BODY WEIGHT; CHITOSAN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 ENZYME SYSTEM; GLUCURONOSYLTRANSFERASE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; KIDNEY; LIPID PEROXIDATION; LIVER; MALE; OLIGOSACCHARIDES; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 84862798717     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.02.022     Document Type: Article

References (47)

1. Baumgardner J.N., Shankar K., Hennings L., Badger T.M., Ronis M.J. A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294:27-38.
2. Chaluvadi M.R., Kinloch R.D., Nyagode B.A., Richardson T.A., Raynor M.J., Sherman M., Antonovic L., Strobel H.W., Dillehay D.L., Morgan E.T. Regulation of hepatic cytochrome P450 expression in mice with intestinal or systemic infections of citrobacter rodentium. Drug Metab. Dispos. 2009, 37:366-374.
3. Chen A.S., Taguchi T., Okamoto H., Danjo K., Sakai K., Matahira Y., Wang M.W., Miwa I. Pharmacokinetics of chitobiose and chitotriose administered intravenously or orally to rats. Biol. Pharm. Bull. 2005, 28:545-548.
4. Chen A.S., Taguchi T., Sakai K., Kikuchi K., Wang M.W., Miwa I. Antioxidant activities of chitobiose and chitotriose. Biol. Pharm. Bull. 2003, 26:1326-1330.
5. Chen A.S., Taguchi T., Sakai K., Matahira Y., Wang M.W., Miwa I. Effect of chitobiose and chitotriose on carbon tetrachloride-induced acute hepatotoxicity in rats. Biol. Pharm. Bull. 2005, 28:1971-1973.
6. Chen H.W., Tsai C.W., Yang J.J., Liu C.T., Kuo W.W., Lii C.K. The combined effects of garlic oil and fish oil on the hepatic antioxidant and drug-metabolizing enzymes of rats. Br. J. Nutr. 2003, 89:189-200.
7. Ding S.J., Shie M.Y., Hoshiba T., Kawazoe N., Chen G., Chang H.C. Osteogenic differentiation and immune response of human bone-marrow-derived mesenchymal stem cells on injectable calcium-silicate-based bone grafts. Tissue Eng. Part A 2010, 16:2343-2354.
8. Gonzalez F.J., Gelboin H.V. Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metab. Rev. 1994, 26:165-183.
9. Guan X., Hoffman B., Dwivedi C., Matthees D.P. A simultaneous liquid chromatography/mass spectrometric assay of glutathione, cysteine, homocysteine and their disulfides in biological samples. J. Pharm. Biomed. Anal. 2003, 31:251-261.
10. Guengerich F.P. Role of cytochrome P450 enzymes in drug-drug interactions. Adv. Pharmacol. 1997, 43:7-35.
11. Habig W.H., Jakoby W.B. Assays for differentiation of glutathione S-transferases. Methods Enzymol. 1981, 77:398-405.
12. Hayes J., Pulford D. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isozymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol. 1995, 30:445-600.
13. Hicks K.B. Isolation of oligomeric fragments of chitin by preparative high-performance liquid chromatography. Methods Enzymol. 1988, 161:410-416.
14. Izume M., Ohtakara A. Preparation of d-glucosamine oligosaccharides by the enzymatic hydrolysis of chitosan. Agric. Biol. Chem. 1987, 4:1189-1191.
15. Jeon Y.J., Kim S.K. Production of chitooligosaccharides using ultrafiltration membrane reactor and their antibacterial activity. Carbohydr. Polym. 2000, 41:133-141.
16. Kondraganti S.R., Jiang W., Jaiswal A.K., Moorthy B. Persistent induction of hepatic and pulmonary phase II enzymes by 3-methylcholanthrene in rats. Toxicol. Sci. 2008, 102:337-342.
17. Krajka-Kuźniak V. Induction of phase II enzymes as a strategy in the chemoprevention of cancer and other degenerative diseases. Postepy Hig. Med. Dosw. 2007, 61:627-638.
18. Kumar S.G., Rahman M.A., Lee S.H., Hwang H.S., Kim H.A., Yun J.W. Plasma proteome analysis for anti-obesity and anti-diabetic potentials of chitosan oligosaccharides in ob/ob mince. Proteomics 2009, 9:2149-2162.
19. Lieber C.S. Prevention and treatment of liver fibrosis based on pathogenesis. Alcohol. Clin. Exp. Res. 1999, 23:944-949.
20. Mendis E., Kim M.M., Rajapakse N., Kim S.K. An in vitro cellular analysis of the radical scavenging efficacy of chitooligosaccharides. Life Sci. 2007, 23:2118-2127.
21. Mennier C.J., Verbeeck R.K. Glucuronidation of R- and S-ketoprofen, acetaminophen, and diflunisal by microsomes of adjuvant induced arthritic rats. Drug Metab. Dispos. 1999, 27:26-31.
22. Nam K.S., Kim M.K., Shon Y.H. Chemopreventive effect of chitosan oligosaccharide against colon carcinogenesis. J. Microbiol. Biotechnol. 2007, 9:1546-1549.
23. Nugon-Baudon L., Roland N., Flinois J.P., Beaune P. Hepatic cytochrome P450 and UDP-glucuronosyl transferase are affected by five sources of dietary fiber in germ-free rats. J. Nutr. 1996, 2:403-409.
24. Nyagode B.A., Lee C.M., Morgan E.T. Modulation of hepatic cytochrome P450s by Citrobacter rodentium infection in interleukin-6- and interferon-{gamma}-null mice. J. Pharmacol. Exp. Ther. 2010, 335:480-488.
25. Omura T., Sato R. The carbon monoxide-binding pigment of liver microsomes. l. Evidence for its hemeprotein nature. J. Biol. Chem. 1964, 239:2370-2379.
26. Park J.K., Chung M.J., Choi H.N., Park Y.I. Effects of the molecular weight and the degree of deacetylation of chitosan oligosaccharides on antitumor activity. Int. J. Mol. Sci. 2011, 12:266-277.
27. Park P.J., Je J.Y., Kim S.K. Free radical scavenging activity of chitooligosaccharides by electron spin resonance spectrometry. J. Agric. Food Chem. 2003, 51:4624-4627.
28. Phillips A.H., Langdon R.G. Hepatic triphosphopyridine nucleotide-cytochrome c reductase: isolation, characterization, and kinetic studies. J. Biol. Chem. 1962, 237:2652-2660.
29. Rendic S. Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab. Rev. 2002, 34:83-448.
30. Ross D. Quinone reductases multitasking in the metabolic world. Drug. Metab. Rev. 2004, 36:639-654.
31. Senevirathne M., Ahn C.B., Je J.Y. Hepatoprotective effect of chitooligosaccharides against tert-butylhydroperoxide-induced damage in Chang liver cells. Carbohydr. Polym. 2011, 83:995-1000.
32. Serron S.C., Dwivedi N., Backes W.L. Ethylbenzene induces microsomal oxygen free radical generation: antibody-directed characterization of the responsible cytochrome P450 enzymes. Toxicol. Appl. Pharmacol. 2000, 164:305-331.
33. Sherry C.L., Kim S.S., Dilger R.N., Bauer L.L., Moon M.L., Tapping R.I., Fahey G.C., Tappenden K.A., Freund G.G. Sickness behavior induced by endotoxin can be mitigated by the dietary soluble fiber, pectin, through up-regulation of IL-4 and Th2 polarization. Brain Behav. Immun. 2010, 24:631-640.
34. Shen J., Barrios R.J., Jaiswal A.K. Inactivation of the quinone oxidoreductases NQO1 and NQO2 strongly elevates the incidence and multiplicity of chemically induced skin tumors. Cancer Res. 2010, 70:1006-1014.
35. Shen K.T., Chen M.H., Chan H.Y., Jeng J.H., Wang Y.J. Inhibitory effects of chitooligosaccharides on tumor growth and metastasis. Food Chem. Toxicol. 2009, 8:1864-1871.
36. Shon Y.H., Nam K.S. Induction of phase II enzymes and inhibition of cytochrome p450 isozymes by chitosanoligosaccharides. J. Microbiol. Biotechnol. 2005, 15:183-187.
37. Sugatani J., Wada T., Osabe M., Yamakawa K., Yoshinari K., Miwa M. Dietary inulin alleviates hepatic steatosis and xenobiotics-induced liver injury in rats fed a high-fat and high-sucrose diet: association with the suppression of hepatic cytochrome P450 and hepatocyte nuclear factor 4alpha expression. Drug. Metab. Dispos. 2006, 10:1677-1687.
38. Traber M.G., Siddens L.K., Leonard S.W., Schock B., Gohil K., Krueger S.K., Cross C.E., Williams D.E. Alpha-tocopherol modulates Cyp3a expression, increases gamma-CEHC production, and limits tissue gamma-tocopherol accumulation in mice fed high gamma-tocopherol diets. Free Radic. Biol. Med. 2005, 38:773-785.
39. Tsvetkov P., Asher G., Reiss V., Shaul Y., Sachs L., Lotem J. Inhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin. Proc. Natl. Acad. Sci. USA 2005, 15:5535-5540.
40. Uehiyama M., Mihara M. Determination of malonaldehyde precursor in tissue by thiobarbituric acid test. Anal. Biochem. 1978, 86:271-278.
41. Woodcroft K.J., Novak R.F. Insulin differentially affects xenobiotic-enhanced cytochrome P-450 (CYP)2E1, CYP2B, CYP3A, and CYP4A expression in primary cultured rat hepatocytes. J. Pharmacol. Exp Ther. 1999, 289:1121-1127.
42. Yao H.T., Chang Y.W., Lan S.J., Chen C.T., Hsu J.T., Yeh T.K. The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes. Life Sci. 2006, 79:2432-2440.
43. Yao H.T., Chang Y.W., Lan S.J., Yeh T.K. The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes. Food Chem. Toxicol. 2008, 46:645-653.
44. Yao H.T., Chiang M.T., Shiu H.S., Chen H.C. Effect of chitin hydrolysate on fecal bifidobacterium and short-chain fatty acid concentrations in rats. Taiwanese J. Agric. Food Sci. 2003, 41:245-253.
45. Yao H.T., Lii C.K., Chou R.H., Lin J.H., Yang H.T., Chiang M.T. Effect of chitosan on hepatic drug-metabolizing enzymes and oxidative stress in rats fed low- and high-fat diets. J. Agric. Food Chem. 2010, 58:5187-5193.
46. Yao H.T., Lin J.H., Chiang M.T., Chiang W., Luo M.N., Lii C.K. Suppressive effect of the ethanolic extract of adlay bran on cytochrome p-450 enzymes in rat liver and lungs. J. Agric. Food Chem. 2011, 8:4306-4314.
47. Yoon H.J., Moon M.E., Park H.S., Kim H.W., Im S.Y., Lee J.H., Kim Y.H. Effects of chitosan oligosaccharide (COS) on the glycerol-induced acute renal failure in vitro and in vivo. Food Chem. Toxicol. 2008, 2:710-716.